Tag: Pharmaceutical industry

Kairos Pharma's IPO aims to fuel its research, development, and expansion in the pharmaceutical sector. The move positions the company ...

The health care sector is witnessing a surge as drug shortages and rising prices create opportunities for growth. However, concerns ...

Shares of Charles River Laboratories surged by 8.7% after the company released optimistic 2024 guidance, positioning it as a top ...

Merrimack Pharmaceuticals is set to dissolve after receiving a $225 million payment for FDA approval. Shareholders will receive a dividend ...

Investment banking firm Jefferies raises Eli Lilly's price target based on optimism over orfoscerinib, indicating strong confidence in its potential. ...

Gilead Sciences plans to acquire CymaBay Therapeutics for $4.3 billion, expanding their liver disease portfolio. The deal is expected to ...

YS Biopharma raises concerns about the validity of an extraordinary general meeting called by shareholders. The company also faces financial ...

AI company Unlearn has secured $50m in funding to develop AI solutions that create digital twins for trial participants, helping ...

GSK and Elegen partner to develop new vaccines and medicines, harnessing Elegen's DNA manufacturing technology. Collaboration aims to expand genetic ...

Discover the promising future for investors in Eli Lilly and Company (NYSE: LLY), a leader in the biopharmaceutical industry, with ...